Cipla has acquired exclusive rights to market skin care products of Percos India worth an estimated Rs 90 crore. The deal includes fast growing brands like Vedaderm, Claz, Actipeel, Tryses and Glycoveda with collective sales of around Rs 10 crore. Technical analysis indicates Cipla stock is in a rising channel and signals to buy in the range of 652-656 levels. HCL Technologies has partnered with Manchester United to explore digital initiatives and create a fan experience lab at Old Trafford stadium. Technical analysis shows HCL stock is in an uptrend and signals to buy in the range of 957-961 levels. US stocks ended mixed as investors awaited a
#ChoiceBroking #MorningTea - Global View: US stocks were modestly lower on Thursday, weighed down by a drop in healthcare and consumer names, while financials advanced
slightly after two more Federal Reserve officials pushed the case for a rate hike.
HPCL is experimenting with dynamic fuel pricing at its retail outlets to compete with private players. Dynamic pricing means fuel prices could change flexibly. If successful, other fuel retailers may have to follow suit. Technically, HPCL stock has been in an uptrend and could continue its upside momentum. Motherson Sumi is acquiring a automotive business unit in Hungary for EUR 10.4 million. Technically, Motherson Sumi stock has broken out of its range and robust upside is expected. Asian shares opened mixed and the Indian market is expected to open flat to positive.
The document provides an analysis of Sun Pharma and LT stocks, recommending a buy on Sun Pharma between 863-867 levels and a sell on LT between 1558-1564 levels. It also discusses recent market movements in India and globally, and provides corporate action updates.
#ChoiceBroking #MorningTea : The S&P 500 and the Dow closed slightly lower on Monday, as a drop in oil prices dragged down energy stocks, while tech names Apple and
Alphabet helped lift the Nasdaq to its highest close in over a year.
The document provides a daily market update and analysis from Choice India Research. It includes:
- News that ITC is planning to offer its distribution network to smaller FMCG companies for a fee to generate new revenue.
- Technical analysis indicating to buy ITC within a price range and target price range.
- News that Dr. Reddy's is recalling over 55,000 tablets in the US market.
- Technical analysis indicating to sell Dr. Reddy's within a price range and target price range.
- Updates on market performance in Europe, Asia and upcoming economic data releases from China.
- Details of upcoming company annual general meetings and dividends.
- Details of bulk deals
NBCC (India) Ltd has won a work order worth Rs 440 crore from ESIC for construction of hospitals in Uttarakhand and Madhya Pradesh. The technical outlook is positive, and the analyst recommends buying NBCC in the range of Rs 251-253 with a target price of Rs 259 and stop loss of Rs 248. IRB Infrastructure has bagged a six-laning project from NHAI. The technical outlook and recommendation is also positive for this stock. Asian shares opened slightly higher ahead of policy decisions from the Bank of Japan and US Federal Reserve. The Indian market is expected to open flat to positive.
- IndiGo has entered into a strategic partnership with Travelport to distribute all of its fares and products worldwide, helping it reach travelers in international markets as it expands its route network.
- The technical outlook suggests buying IndiGo in the range of Rs. 865-870, targeting Rs. 888, with a stop loss of Rs. 856.
- Sunteck Realty reported an over eight-fold jump in quarterly net profit and a rise in total income, with the technical outlook suggesting buying in the range of Rs. 261-263, targeting Rs. 269, with a stop loss of Rs. 258.
Aurobindo Pharma received approval from the US FDA to manufacture and market Tramadol Hydrochloride Extended-release Tablets, which are used to treat moderate-to-severe pain. The approved product has an estimated $56 million market size. Aurobindo now has a total of 217 ANDA approvals from the US FDA. Technically, the stock has broken out of a pennant pattern and is trading above moving averages, suggesting an upward trend. Analyst recommends buying the stock in the range of 824-828 with a target price of 845. RBI has allowed FIIs/RFPIs to invest up to 74% of Shriram Transport Finance's capital. Analyst
#ChoiceBroking #MorningTea - Global View: US stocks were modestly lower on Thursday, weighed down by a drop in healthcare and consumer names, while financials advanced
slightly after two more Federal Reserve officials pushed the case for a rate hike.
HPCL is experimenting with dynamic fuel pricing at its retail outlets to compete with private players. Dynamic pricing means fuel prices could change flexibly. If successful, other fuel retailers may have to follow suit. Technically, HPCL stock has been in an uptrend and could continue its upside momentum. Motherson Sumi is acquiring a automotive business unit in Hungary for EUR 10.4 million. Technically, Motherson Sumi stock has broken out of its range and robust upside is expected. Asian shares opened mixed and the Indian market is expected to open flat to positive.
The document provides an analysis of Sun Pharma and LT stocks, recommending a buy on Sun Pharma between 863-867 levels and a sell on LT between 1558-1564 levels. It also discusses recent market movements in India and globally, and provides corporate action updates.
#ChoiceBroking #MorningTea : The S&P 500 and the Dow closed slightly lower on Monday, as a drop in oil prices dragged down energy stocks, while tech names Apple and
Alphabet helped lift the Nasdaq to its highest close in over a year.
The document provides a daily market update and analysis from Choice India Research. It includes:
- News that ITC is planning to offer its distribution network to smaller FMCG companies for a fee to generate new revenue.
- Technical analysis indicating to buy ITC within a price range and target price range.
- News that Dr. Reddy's is recalling over 55,000 tablets in the US market.
- Technical analysis indicating to sell Dr. Reddy's within a price range and target price range.
- Updates on market performance in Europe, Asia and upcoming economic data releases from China.
- Details of upcoming company annual general meetings and dividends.
- Details of bulk deals
NBCC (India) Ltd has won a work order worth Rs 440 crore from ESIC for construction of hospitals in Uttarakhand and Madhya Pradesh. The technical outlook is positive, and the analyst recommends buying NBCC in the range of Rs 251-253 with a target price of Rs 259 and stop loss of Rs 248. IRB Infrastructure has bagged a six-laning project from NHAI. The technical outlook and recommendation is also positive for this stock. Asian shares opened slightly higher ahead of policy decisions from the Bank of Japan and US Federal Reserve. The Indian market is expected to open flat to positive.
- IndiGo has entered into a strategic partnership with Travelport to distribute all of its fares and products worldwide, helping it reach travelers in international markets as it expands its route network.
- The technical outlook suggests buying IndiGo in the range of Rs. 865-870, targeting Rs. 888, with a stop loss of Rs. 856.
- Sunteck Realty reported an over eight-fold jump in quarterly net profit and a rise in total income, with the technical outlook suggesting buying in the range of Rs. 261-263, targeting Rs. 269, with a stop loss of Rs. 258.
Aurobindo Pharma received approval from the US FDA to manufacture and market Tramadol Hydrochloride Extended-release Tablets, which are used to treat moderate-to-severe pain. The approved product has an estimated $56 million market size. Aurobindo now has a total of 217 ANDA approvals from the US FDA. Technically, the stock has broken out of a pennant pattern and is trading above moving averages, suggesting an upward trend. Analyst recommends buying the stock in the range of 824-828 with a target price of 845. RBI has allowed FIIs/RFPIs to invest up to 74% of Shriram Transport Finance's capital. Analyst
Sun Pharmaceutical Industries is seeking shareholder approval to raise up to Rs 12,000 crore through convertible debentures or a QIP placement to fund expansion and acquisitions. Following its merger with Ranbaxy, the company has been restructuring its business. KEC International has secured new orders worth Rs 668 crore for transmission, distribution, cables and renewable projects in India and other countries. Asian stocks traded mostly higher following gains on Wall Street, with Chinese markets leading after reopening from a weeklong holiday.
The document provides a market summary and analysis from Choice Broking. It discusses the performance of US, Asian, and Indian markets. The US market slipped as some company results disappointed. Asian shares also fell following the US. The Indian market is expected to open lower tracking Asian indices. It also provides recommendations to buy two Indian stocks, KPIT and STCINDIA, based on technical analysis showing positive momentum.
The document discusses several stocks and provides technical analysis and recommendations. It suggests buying Dishman Pharmaceuticals between Rs. 135-136 with a target price of Rs. 139 and stop loss of Rs. 133.50. It also recommends buying Bharti Airtel between Rs. 354-356 with a target of Rs. 363.50 and stop loss of Rs. 350.50. Asia markets opened higher on positive global cues and the Indian market is likely to react positively as well.
- The Reserve Bank of India has approved Canada Pension Plan Investment Board's request to increase its stake in Kotak Mahindra Bank to over 5% and below 10% of the bank's paid-up capital.
- The technical outlook suggests buying Kotak Mahindra Bank in the range of Rs. 803-806, with a target price of Rs. 822.50 and stop loss of Rs. 795.50.
- The technical outlook also suggests buying BPCL in the range of Rs. 598-602, with a target price of Rs. 614.50 and stop loss of Rs. 592.
- US stocks ended lower as gains in healthcare were offset by losses in telecoms following disappointing earnings from Verizon. The Dow and S&P 500 closed slightly lower while the Nasdaq dipped 0.09%.
- Asian stocks slipped with crude oil prices falling, dampening risk sentiment. The dollar hovered near a seven-month high against its peers as the ECB shot down talk of tapering its monetary easing.
- Two stocks, JKLAKSHMI and VIPIND, are recommended as buy opportunities based on technical analysis showing breakouts, rising trends, and momentum indicators pointing to further upside.
- Cipla reported a 21.22% rise in net profit to Rs. 407.38 crore for the quarter ended September 30, 2015 compared to the same quarter last year. Total income increased 23.50% to Rs. 3103.43 crore.
- On a technical outlook, Cipla stock has taken support at 650 levels and momentum indicators point to a bounce back in prices. It recommends buying in the range of 655-659 with a target of 673 and stop loss of 648.
- Union Bank of India reported a 77.24% rise in net profit to Rs. 658.16 crore for the quarter ended September 30, 2015 compared to a net loss in
Adani Ports and Special Economic Zone reported a 31% rise in Q1 net profit to Rs. 835.71 crore compared to Rs. 638.93 crore in the same period last year. Total income rose 11% to Rs. 2,083.72 crore. Power Finance Corporation approved the merger of its wholly-owned subsidiary PFC Green Energy Limited with PFC. The document provides analysis and recommendations for buying Adani Ports and PFC based on technical indicators. It also includes market news and upcoming company results.
- The document provides technical analysis on two stocks - Godrej Consumer Products Ltd. (GCPL) and TVS Motor Company. It recommends buying GCPL between Rs. 1214-1223 with a target of Rs. 1248 and stop loss of Rs. 1201 and buying TVS Motor between Rs. 233-235 with a target of Rs. 242 and stop loss of Rs. 229.
- It also provides updates on global markets, key Indian indices and upcoming corporate actions and results calendar. US stocks rose on Friday while Asian markets opened mixed on Monday as traders await the US Federal Reserve meeting this week.
Reliance Industries reported an 18.1% rise in net profit for the April-June quarter to Rs. 7,113 crore, driven by higher refining margins. Technical analysis indicates the stock could continue its upward movement. LIC Housing Finance reported a 6.7% rise in net profit for the first quarter to Rs. 407.84 crore, with total income rising 14%. Technical analysis also points to further gains in this stock. Asian markets opened flat ahead of light data week, while the failed coup in Turkey saw the lira tumble against the dollar and euro.
1) US stocks fell on Friday led by a 4.3% drop in Oracle shares after its revenue missed estimates, while defensive sectors like real estate and utilities gained. Asian shares steadied after China agreed to return a seized US drone.
2) The document provides updates on the US, Asian and Indian stock markets. It also lists recent corporate actions and an upcoming earnings calendar.
3) The document concludes with recommendations to buy Exide Industries and sell Tata Power based on technical analysis indicators.
The document provides a summary of global and Asian stock market performance and Indian market outlook. It also recommends two stocks, EROSMEDIA and TRITURBINE, for buying based on technical analysis showing bullish patterns and indicators. A list of companies reporting earnings is also included.
#ChoiceBroking #MorningTea: Global View- Wall Street rose on Friday, clinching the fourth straight positive week for the stock market, boosted by strength in telecom stalwarts
AT&T and Verizon.
The Reserve Bank of India increased the limit of foreign institutional investment in Info Edge (India) to 50% of its paid-up capital from the previous limit of 40%. Info Edge owns the leading job portal naukri.com. The Cabinet approved auctioning 69 small and marginal oilfields of ONGC and Oil India to private and foreign firms. Technical analysis indicates buying Info Edge between 752-757 and ONGC between 452-455 based on chart patterns and momentum indicators.
Adani Ports and Special Economic Zone Ltd raised Rs. 1000 crores through issuing non-convertible debentures on private placement basis. The stock is recommended as a buy based on technical analysis, expecting it to rise from its current price of Rs. 215-217 to a target of Rs. 221.50. NTPC achieved savings of Rs. 550 crores per month due to coal rationalization and reduced imports. The stock is recommended as a buy based on technical analysis, with a target price of Rs. 158.50. Asian markets were mixed in early trade on Tuesday with SoftBank shares falling 10% as the Japanese market reopened.
Idea Cellular received shareholder approval to raise up to Rs. 10,000 crore through private placement of non-convertible securities. The company also received approval for routine businesses such as declaring dividends and appointing directors. Technical analysis indicates Idea Cellular and NMDC stocks could be bought within certain price ranges, with targets and stop losses provided. Asian markets opened higher tracking gains on Wall Street, although caution remained due to upcoming economic data releases from China and other regions.
- Havells India reported a 22% rise in net profit for the second quarter ended September 30, 2016 to Rs. 145.79 crore compared to Rs. 119.53 crore during the same period last year. Total income grew 9.8% to Rs. 1,584.63 crore.
- Marksans Pharma received US FDA approval for Paricalcitol capsules used to treat hyperparathyroidism.
- Asian shares edged up after Wall Street gained on encouraging corporate earnings and optimism about upcoming Chinese economic data. The Indian market is expected to open gap up tracking Asian indices.
The document provides a daily market summary and analysis for November 17th, 2016. It discusses the performance of the US, Asian, and Indian markets the previous day. It also provides technical analysis and recommendations for two Indian stocks, TECHM and SUNPHARMA, suggesting buy and sell signals. Additionally, it lists several corporate actions and an upcoming earnings calendar. The document is the daily morning tea report from Choice Broking research analysts.
Sun Pharmaceutical Industries is seeking shareholder approval to raise up to Rs 12,000 crore through convertible debentures or a QIP placement to fund expansion and acquisitions. Following its merger with Ranbaxy, the company has been restructuring its business. KEC International has secured new orders worth Rs 668 crore for transmission, distribution, cables and renewable projects in India and other countries. Asian stocks traded mostly higher following gains on Wall Street, with Chinese markets leading after reopening from a weeklong holiday.
The document provides a market summary and analysis from Choice Broking. It discusses the performance of US, Asian, and Indian markets. The US market slipped as some company results disappointed. Asian shares also fell following the US. The Indian market is expected to open lower tracking Asian indices. It also provides recommendations to buy two Indian stocks, KPIT and STCINDIA, based on technical analysis showing positive momentum.
The document discusses several stocks and provides technical analysis and recommendations. It suggests buying Dishman Pharmaceuticals between Rs. 135-136 with a target price of Rs. 139 and stop loss of Rs. 133.50. It also recommends buying Bharti Airtel between Rs. 354-356 with a target of Rs. 363.50 and stop loss of Rs. 350.50. Asia markets opened higher on positive global cues and the Indian market is likely to react positively as well.
- The Reserve Bank of India has approved Canada Pension Plan Investment Board's request to increase its stake in Kotak Mahindra Bank to over 5% and below 10% of the bank's paid-up capital.
- The technical outlook suggests buying Kotak Mahindra Bank in the range of Rs. 803-806, with a target price of Rs. 822.50 and stop loss of Rs. 795.50.
- The technical outlook also suggests buying BPCL in the range of Rs. 598-602, with a target price of Rs. 614.50 and stop loss of Rs. 592.
- US stocks ended lower as gains in healthcare were offset by losses in telecoms following disappointing earnings from Verizon. The Dow and S&P 500 closed slightly lower while the Nasdaq dipped 0.09%.
- Asian stocks slipped with crude oil prices falling, dampening risk sentiment. The dollar hovered near a seven-month high against its peers as the ECB shot down talk of tapering its monetary easing.
- Two stocks, JKLAKSHMI and VIPIND, are recommended as buy opportunities based on technical analysis showing breakouts, rising trends, and momentum indicators pointing to further upside.
- Cipla reported a 21.22% rise in net profit to Rs. 407.38 crore for the quarter ended September 30, 2015 compared to the same quarter last year. Total income increased 23.50% to Rs. 3103.43 crore.
- On a technical outlook, Cipla stock has taken support at 650 levels and momentum indicators point to a bounce back in prices. It recommends buying in the range of 655-659 with a target of 673 and stop loss of 648.
- Union Bank of India reported a 77.24% rise in net profit to Rs. 658.16 crore for the quarter ended September 30, 2015 compared to a net loss in
Adani Ports and Special Economic Zone reported a 31% rise in Q1 net profit to Rs. 835.71 crore compared to Rs. 638.93 crore in the same period last year. Total income rose 11% to Rs. 2,083.72 crore. Power Finance Corporation approved the merger of its wholly-owned subsidiary PFC Green Energy Limited with PFC. The document provides analysis and recommendations for buying Adani Ports and PFC based on technical indicators. It also includes market news and upcoming company results.
- The document provides technical analysis on two stocks - Godrej Consumer Products Ltd. (GCPL) and TVS Motor Company. It recommends buying GCPL between Rs. 1214-1223 with a target of Rs. 1248 and stop loss of Rs. 1201 and buying TVS Motor between Rs. 233-235 with a target of Rs. 242 and stop loss of Rs. 229.
- It also provides updates on global markets, key Indian indices and upcoming corporate actions and results calendar. US stocks rose on Friday while Asian markets opened mixed on Monday as traders await the US Federal Reserve meeting this week.
Reliance Industries reported an 18.1% rise in net profit for the April-June quarter to Rs. 7,113 crore, driven by higher refining margins. Technical analysis indicates the stock could continue its upward movement. LIC Housing Finance reported a 6.7% rise in net profit for the first quarter to Rs. 407.84 crore, with total income rising 14%. Technical analysis also points to further gains in this stock. Asian markets opened flat ahead of light data week, while the failed coup in Turkey saw the lira tumble against the dollar and euro.
1) US stocks fell on Friday led by a 4.3% drop in Oracle shares after its revenue missed estimates, while defensive sectors like real estate and utilities gained. Asian shares steadied after China agreed to return a seized US drone.
2) The document provides updates on the US, Asian and Indian stock markets. It also lists recent corporate actions and an upcoming earnings calendar.
3) The document concludes with recommendations to buy Exide Industries and sell Tata Power based on technical analysis indicators.
The document provides a summary of global and Asian stock market performance and Indian market outlook. It also recommends two stocks, EROSMEDIA and TRITURBINE, for buying based on technical analysis showing bullish patterns and indicators. A list of companies reporting earnings is also included.
#ChoiceBroking #MorningTea: Global View- Wall Street rose on Friday, clinching the fourth straight positive week for the stock market, boosted by strength in telecom stalwarts
AT&T and Verizon.
The Reserve Bank of India increased the limit of foreign institutional investment in Info Edge (India) to 50% of its paid-up capital from the previous limit of 40%. Info Edge owns the leading job portal naukri.com. The Cabinet approved auctioning 69 small and marginal oilfields of ONGC and Oil India to private and foreign firms. Technical analysis indicates buying Info Edge between 752-757 and ONGC between 452-455 based on chart patterns and momentum indicators.
Adani Ports and Special Economic Zone Ltd raised Rs. 1000 crores through issuing non-convertible debentures on private placement basis. The stock is recommended as a buy based on technical analysis, expecting it to rise from its current price of Rs. 215-217 to a target of Rs. 221.50. NTPC achieved savings of Rs. 550 crores per month due to coal rationalization and reduced imports. The stock is recommended as a buy based on technical analysis, with a target price of Rs. 158.50. Asian markets were mixed in early trade on Tuesday with SoftBank shares falling 10% as the Japanese market reopened.
Idea Cellular received shareholder approval to raise up to Rs. 10,000 crore through private placement of non-convertible securities. The company also received approval for routine businesses such as declaring dividends and appointing directors. Technical analysis indicates Idea Cellular and NMDC stocks could be bought within certain price ranges, with targets and stop losses provided. Asian markets opened higher tracking gains on Wall Street, although caution remained due to upcoming economic data releases from China and other regions.
- Havells India reported a 22% rise in net profit for the second quarter ended September 30, 2016 to Rs. 145.79 crore compared to Rs. 119.53 crore during the same period last year. Total income grew 9.8% to Rs. 1,584.63 crore.
- Marksans Pharma received US FDA approval for Paricalcitol capsules used to treat hyperparathyroidism.
- Asian shares edged up after Wall Street gained on encouraging corporate earnings and optimism about upcoming Chinese economic data. The Indian market is expected to open gap up tracking Asian indices.
The document provides a daily market summary and analysis for November 17th, 2016. It discusses the performance of the US, Asian, and Indian markets the previous day. It also provides technical analysis and recommendations for two Indian stocks, TECHM and SUNPHARMA, suggesting buy and sell signals. Additionally, it lists several corporate actions and an upcoming earnings calendar. The document is the daily morning tea report from Choice Broking research analysts.
Ultratech Cement is in discussions with Jaiprakash Associates to acquire its 2.2 million tonne Bhilai cement unit in Chhattisgarh. Both companies have approached SAIL, which owns a 26% stake in the facility, for approval of the deal. In 2014, UltraTech Cement had acquired two cement units and power plants from Jaiprakash Associates in Madhya Pradesh for Rs. 5,400 crore. IRB Infrastructure will hand over two toll road projects to the state government upon completion of their concession periods. The company received communication that the Maharashtra government is considering buying back its Kolhapur Integrated Road Development Project.
Aurobindo Pharma received final approval from the US FDA to manufacture and market generic versions of Abilify tablets in various strengths. The approved product has an estimated US market size of $7.3 billion. Tata Motors' subsidiary Jaguar Land Rover will invest $2 billion in the first phase to set up a new manufacturing plant in Slovakia and expects to start production by 2018. Asian stocks advanced on Monday tracking a stronger lead from Wall Street on Friday, while markets in Japan were closed for a holiday.
KNR Constructions Limited is an infrastructure company focused on road construction. The stock price has fallen recently but technical indicators suggest it has completed its downward move and may begin an upward trend. Fundamentals also appear positive, with a large order backlog providing earnings visibility and healthy margins. The stock currently trades at a discount to peers and offers upside potential of 25% over the next 6 months based on technical and fundamental factors.
Drugmaker Suven Life Sciences Ltd secured four product patents from Eurasia, Europe, Israel and Macau for its New Chemical Entities. These patents, valid through 2030, cover selective 5-HT compounds being developed to treat cognitive disorders like Alzheimer's, ADHD, Huntington's and Parkinson's diseases. Suven CEO said they are pleased to receive these patents for molecules in the CNS area with high unmet medical need and market potential globally. Oil prices extended their decline on worries over global oversupply and slowing demand growth. Asian markets opened lower on Monday following a slump in US stocks on Friday due to concerns over declining oil prices and China's yuan. Indian shares may open weak, tracking Asian peers and ahead of
IDFC received RBI approval to utilize Rs 2,500 crore in non-distributable reserves for provisions against bad loans as it transitions to universal banking. This will result in an additional Rs 1,600 crore provision this fiscal and reduce its net worth. REC received shareholder approval to raise up to Rs 42,000 crore through bond issuances over the next year. Technical indicators suggest buying IDFC between Rs 137.50-139 and REC between Rs 272-274. US stocks ended higher on Monday with gains in Apple and financials, though biotech shares fell on price control concerns. Asian markets were up around 0.5% while Japan was closed for a holiday.
1) India's industrial production grew by 6.4% in August 2015, the fastest pace in nearly three years, driven by strong growth in the manufacturing and mining sectors.
2) Fifteen of twenty-two manufacturing industry groups showed positive growth in August, with capital goods output growing 21.8%, indicating rising investment. Consumer durable output expanded 17%.
3) For the first five months of the current fiscal year, manufacturing grew 4.6% compared to 2% in the year-ago period, showing improved demand as inflation has eased. Overall industrial growth was forecast to continue benefiting from lower oil prices and interest rates.
In the last month, crude oil prices gained over 11% on Nymex and over 13% on Brent due to estimates of production freezes by OPEC in September and rising demand from countries like India, China, and Russia. However, further upside is capped by slowing global economic growth forecasts. Natural gas production is expected to rise marginally due to low prices and declining rig activity, while demand is forecast to increase from the power sector. For both commodities, prices are expected to trade in defined ranges over the coming month.
The document provides a daily market summary and analysis from Choice Broking. It discusses the performance of the US, Asian, and Indian markets. The US markets hit new record highs as stocks continued rising after Trump's election. Asian shares also rose tracking the strong US performance. In India, the RBI will withdraw a temporary cash reserve ratio hike. Several companies including IOC, BPCL and HPCL plan to set up India's largest refinery. Trading recommendations are provided for two stocks, Chambal Fertilizers and SCI, based on technical analysis.
- US stocks rose to new record highs on optimism about economic stimulus and tax cuts under President Trump. Unemployment claims fell, pointing to continued economic strength.
- Asian shares were flat but on track for weekly gains. The ECB trimmed its asset purchase program but extended it longer than expected.
- The document provides stock recommendations and analysis for FSL and JAIN IRRIGATION based on technical indicators, and includes a corporate action calendar and disclaimer.
The document discusses the Indian pharmaceutical sector facing regulatory hurdles in international markets like the US due to a shortage of drug inspectors. It notes there are around 1,500 inspectors for over 10,000 factories producing pharmaceutical products in India. The sector is facing challenges in markets like the US and EU. It provides technical analysis on Cipla, recommending selling within the range of 623-627, targeting 610. It also recommends buying BHEL within 167-169, targeting 173. It includes updates on US stocks, Asian stocks, and expected opening of Indian shares.
Reliance Capital aims to more than double its customer base to 50 million over the next 3-5 years. The company currently has a customer base of 20 million across insurance, mutual funds, brokerage and other financial services. In Q1 FY2015-16, Reliance Capital reported total income of Rs. 9,998 crore, up 12% year-over-year, while net profit stood at Rs. 1,101 crore, up 10% year-over-year. Technical indicators show the stock is in an uptrend and analysts recommend buying the stock between Rs. 542-545 for a target of Rs. 555 with a stop loss of Rs. 537.
Lupin has increased the price of its generic diabetes drug Fortamet by three times for certain dosages. Despite the price hike, Lupin's drug is still 15% cheaper than the innovator drug. Fortamet has two generic competitors in the market - Lupin with 60% market share and Mylan, which has not yet launched its generic version. The current market size for Fortamet is estimated at $170 million. Technical analysis indicates Lupin and HCC stocks could be bought within certain price ranges. Global markets were mixed with the US closing slightly lower and Asian markets trading down due to weak Chinese economic data.
Idea Cellular added 33.75 lakh new mobile subscribers in November, bringing its total subscriber count to 17.06 crore. The document recommends buying Idea Cellular shares between Rs. 136.50-138, targeting Rs. 141 with a stop loss of Rs. 135. It also recommends buying Adani Power shares between Rs. 30-30.70, targeting Rs. 31.70 with a stop loss of Rs. 29.50. The document provides daily technical analysis on stocks and updates on corporate actions and result calendars.
The S&P 500 fell for a fourth consecutive session weighed by sectors sensitive to economic growth amid disappointing earnings and lingering concerns over Trump's priorities. Asian shares were mixed as investors parsed economic data from Asia ahead of the FOMC meeting. The Indian market is expected to open higher tracking Asian indices. Stocks mentioned include ABFRL recommended for buy and IDFC recommended for sell based on technical analysis.
The document discusses several topics:
1) Drug company Cipla received approval to market a generic version of an antidepressant drug in the US market, worth $792 million annually.
2) Technical analysis recommends buying Cipla stock between 574-576 with a target price of 587.50.
3) Canara Bank launched a mobile payments app allowing customers to pay and collect money between accounts across banks.
4) Asian stock markets opened lower following modest losses on Wall Street as investors awaited upcoming US jobs data that could influence interest rate decisions.
Shasun Pharmaceuticals received US FDA approval to market its pain relief drug Carisoprodol in the US. The approval is for 250mg and 350mg strengths which have annual sales of $38 million. Shasun expects to capture the $16 million market for the 250mg tablets as the first generic player.
Apollo Tyres will acquire the German tyre retail company Reifencom GmbH for €45.6 million. Reifencom has annual turnover of €147 million and a presence in Germany and other European countries. The acquisition will help Apollo improve its distribution network in Europe.
Asian stock markets advanced led by energy and airline stocks tracking the rally on Wall Street where major indices rose over
The US and Asian stock markets closed lower as investors awaited corporate earnings reports and details on Trump's economic policies. In India, the equity market is expected to open flat to positive tracking Asian indices. Two stocks, Torntpower and Crompton Greaves, are recommended as buy opportunities based on technical analysis showing breakouts and rising momentum. The document also provides a corporate action calendar and details of bulk deals by various investors.
- Vedanta's subsidiary TSPL commissioned the third 660 MW unit of its 1980 MW Talwandi Sabo thermal power plant in Punjab. TSPL had signed a PPA with Punjab State Power Corporation for establishing the 1980 MW coal-based commercial power plant.
- Dr. Reddy's launched generic versions of heart drug Nitrostat in the US market. The brand drug had US sales of around $108 million last year.
- Asian shares rebounded after doubts over the likelihood of a US Fed rate hike in September weakened the dollar. The Indian market is expected to open flat to higher tracking Asian indices.
1) Pharma firm Granules India has entered into a licensing pact with US pharma Windlas to market and distribute four products in the US. Windlas will receive milestone payments and profits from sales.
2) Technical analysis indicates Granules stock could be bought between Rs. 140-142, targeting Rs. 146, with a stop loss of Rs. 138.
3) Regulator CDSCO found quality issues in Alkem Labs' diabetes drug Glimekem for the third time in a year, asking the company to recall specific batches. On technical grounds, Alkem stock could be sold between Rs. 1380-1387, targeting Rs. 1350, with a stop loss of Rs
The document provides a morning market update and analysis from Choice Broking on November 22nd, 2016. It summarizes that US markets rose on optimism around Trump policies and higher oil prices. Asian markets also rose tracking US gains. Domestically, the Indian market is expected to open higher tracking Asian indices. It then provides technical recommendations to buy two stocks, Naukri and Mphasis, based on chart patterns and momentum indicators. The document also includes recent bulk deals, stock in news, result calendar and corporate actions.
The document provides a summary of US, Asian, and Indian markets. It notes that declines in energy and financial stocks weighed on the S&P 500, while the Nasdaq reached a record high. In Asian markets, shares opened lower following declines in the Dow and a plunge in oil prices. It also provides short updates on various Indian companies and proposed partnerships. Technical analyses are given for two stocks, GSFC and ADANITRANS, recommending buy ranges and price targets.
The document discusses Indian Oil Corporation's (IOCL) board approval for expansion projects at its Barauni and Panipat refineries costing over Rs. 1,500 crore. It also provides a technical analysis for IOCL, recommending buying between Rs. 580-583 for a target of Rs. 595. A technical analysis is also given for HCL Technologies, recommending buying between Rs. 795-800 for a target of Rs. 816. Asian markets are cautiously higher to start the new quarter while the Indian market is expected to open flat to positive.
The document provides a summary of global and Asian stock market performance and recommends two Indian stocks - SNOWMAN and RADICO - for trading. It notes that US stocks slipped on Monday as oil prices dropped, while Asian markets were also negative following sluggish global equities. In India, the equity market is expected to open flat tracking Asian indices. Technical analysis is provided for SNOWMAN and RADICO stocks to recommend buying ranges and price targets.
Financial Assets: Debit vs Equity Securities.pptxWrito-Finance
financial assets represent claim for future benefit or cash. Financial assets are formed by establishing contracts between participants. These financial assets are used for collection of huge amounts of money for business purposes.
Two major Types: Debt Securities and Equity Securities.
Debt Securities are Also known as fixed-income securities or instruments. The type of assets is formed by establishing contracts between investor and issuer of the asset.
• The first type of Debit securities is BONDS. Bonds are issued by corporations and government (both local and national government).
• The second important type of Debit security is NOTES. Apart from similarities associated with notes and bonds, notes have shorter term maturity.
• The 3rd important type of Debit security is TRESURY BILLS. These securities have short-term ranging from three months, six months, and one year. Issuer of such securities are governments.
• Above discussed debit securities are mostly issued by governments and corporations. CERTIFICATE OF DEPOSITS CDs are issued by Banks and Financial Institutions. Risk factor associated with CDs gets reduced when issued by reputable institutions or Banks.
Following are the risk attached with debt securities: Credit risk, interest rate risk and currency risk
There are no fixed maturity dates in such securities, and asset’s value is determined by company’s performance. There are two major types of equity securities: common stock and preferred stock.
Common Stock: These are simple equity securities and bear no complexities which the preferred stock bears. Holders of such securities or instrument have the voting rights when it comes to select the company’s board of director or the business decisions to be made.
Preferred Stock: Preferred stocks are sometime referred to as hybrid securities, because it contains elements of both debit security and equity security. Preferred stock confers ownership rights to security holder that is why it is equity instrument
<a href="https://www.writofinance.com/equity-securities-features-types-risk/" >Equity securities </a> as a whole is used for capital funding for companies. Companies have multiple expenses to cover. Potential growth of company is required in competitive market. So, these securities are used for capital generation, and then uses it for company’s growth.
Concluding remarks
Both are employed in business. Businesses are often established through debit securities, then what is the need for equity securities. Companies have to cover multiple expenses and expansion of business. They can also use equity instruments for repayment of debits. So, there are multiple uses for securities. As an investor, you need tools for analysis. Investment decisions are made by carefully analyzing the market. For better analysis of the stock market, investors often employ financial analysis of companies.
2. Elemental Economics - Mineral demand.pdfNeal Brewster
After this second you should be able to: Explain the main determinants of demand for any mineral product, and their relative importance; recognise and explain how demand for any product is likely to change with economic activity; recognise and explain the roles of technology and relative prices in influencing demand; be able to explain the differences between the rates of growth of demand for different products.
1. Elemental Economics - Introduction to mining.pdfNeal Brewster
After this first you should: Understand the nature of mining; have an awareness of the industry’s boundaries, corporate structure and size; appreciation the complex motivations and objectives of the industries’ various participants; know how mineral reserves are defined and estimated, and how they evolve over time.
5 Tips for Creating Standard Financial ReportsEasyReports
Well-crafted financial reports serve as vital tools for decision-making and transparency within an organization. By following the undermentioned tips, you can create standardized financial reports that effectively communicate your company's financial health and performance to stakeholders.
OJP data from firms like Vicinity Jobs have emerged as a complement to traditional sources of labour demand data, such as the Job Vacancy and Wages Survey (JVWS). Ibrahim Abuallail, PhD Candidate, University of Ottawa, presented research relating to bias in OJPs and a proposed approach to effectively adjust OJP data to complement existing official data (such as from the JVWS) and improve the measurement of labour demand.
Lecture slide titled Fraud Risk Mitigation, Webinar Lecture Delivered at the Society for West African Internal Audit Practitioners (SWAIAP) on Wednesday, November 8, 2023.
Abhay Bhutada, the Managing Director of Poonawalla Fincorp Limited, is an accomplished leader with over 15 years of experience in commercial and retail lending. A Qualified Chartered Accountant, he has been pivotal in leveraging technology to enhance financial services. Starting his career at Bank of India, he later founded TAB Capital Limited and co-founded Poonawalla Finance Private Limited, emphasizing digital lending. Under his leadership, Poonawalla Fincorp achieved a 'AAA' credit rating, integrating acquisitions and emphasizing corporate governance. Actively involved in industry forums and CSR initiatives, Abhay has been recognized with awards like "Young Entrepreneur of India 2017" and "40 under 40 Most Influential Leader for 2020-21." Personally, he values mindfulness, enjoys gardening, yoga, and sees every day as an opportunity for growth and improvement.
In a tight labour market, job-seekers gain bargaining power and leverage it into greater job quality—at least, that’s the conventional wisdom.
Michael, LMIC Economist, presented findings that reveal a weakened relationship between labour market tightness and job quality indicators following the pandemic. Labour market tightness coincided with growth in real wages for only a portion of workers: those in low-wage jobs requiring little education. Several factors—including labour market composition, worker and employer behaviour, and labour market practices—have contributed to the absence of worker benefits. These will be investigated further in future work.
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby...Donc Test
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting, 8th Canadian Edition by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Ebook Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Pdf Solution Manual For Financial Accounting 8th Canadian Edition Pdf Download Stuvia Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Financial Accounting 8th Canadian Edition Ebook Download Stuvia Financial Accounting 8th Canadian Edition Pdf Financial Accounting 8th Canadian Edition Pdf Download Stuvia
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby...
Morning Tea 04/09/2015
1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Cipla, one of India'sleading generic pharmaceutical companies has reportedlyacquired the exclusive rights to market skin care productsof Percos
India. This deal may be worth an estimated Rs 90 crore. The company will market few fast growing brands like Vedaderm, Claz, Actipeel, Tryses
and Glycoveda, which have collective sales of around Rs 10 crore. Cipla is a global pharmaceutical company which uses cutting edge technology
and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected
pharmaceuticalnames inIndiaaswell asacrossmore than150 countries. The company's portfolioincludes over 1500 productsacrosswide range
oftherapeuticcategorieswithonequalitystandardglobally.
Technical Outlook : The stock has been trading in rising channel formation since last couples of days and it has taken support at lower band of
channelat648levelsonhourlychart.Moreover,pricesaretradingabove100EMAwhichsuggestingmediumtermtolongtermtrendisup.On
the other hand, momentum indicator RSI has moved above 40 level and about to make positive crossover, which gives positive confirmation
totheprices.Sofortradingprospective,onecouldBuyintherangeof652-656 forthetargetof663-670 levels.
HCL Technologies, a leading global IT services provider, has entered into a global partnership with Manchester United. As part of this partnership
HCL and Manchester United will work together to explore and unveil a number of digital initiatives to transform the experience of the Club's 659
million global followers. As the first step, HCL will create a state-of-the-art United Xperience Lab to be housed within the iconic Old Trafford
stadium, which will make it the seventh such lab across the world. Within the lab, HCL and Manchester United will explore revolutionary ways in
which the club uses technology to create a unified fan experience for supporters; and in the process set a new engagement benchmark in the
worldofsport.HCLTechnologiesisaleadingglobalITservicescompanyworkingwithclientsin theareasthatimpactandredefinethecoreoftheir
businesses.
Technical Outlook: On daily chart, prices have been trading in horizontal channel formation as well as trading with the support 100 DEMA at
939.60 levels, which indicates the short term trend remain bullish. Recently price has formed small bullish candle stick with above average
volumes. The momentum indictor RSI has remained above 40 levels with positive crossover, which show positive breath in the stock. So for
tradingprospective,onecouldBuyintherangeof957-961 forthetargetof971-981 levels.
CIPLA
HCLTECH
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
04th Sept 2015
Buy in the range of 957-961 with of SL 947 for the Target of 971-981
Buy in the range of 652-656 with of SL 645 for the Target of 663-670
USstocksendedslightlyhigheronThursdayasinvestors,onedgeafterrecentturmoilinChina'smarkets,lookedtowardakeyUSjobsreportthatmayfigure
intheFederalReserve's decisionaboutwhentoliftinterestrates.MajorUSindices atonepointrosestronglyover 1percentbutrelinquishedthosegainsto
dipintonegativeterritoryasworriesaboutChina'seconomyweighedontraders'minds,thoughtheDowJonesindustrialaverageandS&P500managedto
hold on to end modestly higher. It was the second consecutive day of increases after over two weeks of China-driven market turmoil that has left the S&P
500 down 9 percent from its all-time high in May. European Central Bank chief Mario Draghi hinted at additional stimulus measures for the euro zone,
helpingdriveWallStreet'searlygains.HisremarkscameadayaheadofthemonthlyUSnonfarmpayrollsdata,whichisexpectedtoshowthattheeconomy
added 220,000 nonfarm jobs in August, upfrom 215,000 in July.TheDow Jones industrial averagerose 0.14 percentto 16,374.76 and the S&P 500 gained
0.12percentto1,951.13points.TheNasdaqCompositeended0.35percentlowerat4,733.50.
Asian stocks traded mixed on the final trading day of the week, mirroring the lead from Wall Street overnight. Market volatility was high in early trade as
investors awaited the nonfarm payrolls report for August that may play a crucial role in the Federal Reserve's decision about when to lift interest rates.
China's stock market remains closed for a second day as the country commemorates the end of World War Two. The absence of China-induced market
volatility could bode well for sentiment in the region. However, neighboring Hong Kong markets will reopen for trade today after being shut on Thursday.
Japan's benchmark Nikkei 225 index down by 1.14% at 17976.77, South Korea's Kospi index edged down by 1.03% to 1896 levels. However, HangSeng
index traded with marginally gain with 0.39% at 21016.50. Back to home, TheIndian equity marketis expected toopen in the red today. TheSGX Nifty is
tradingat7819.50, down22points.
2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
Corporate Action / Result Calendar
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
04th Sept 2015
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Corporate Action:
Crest Ventures Limited; Annual General Meeting/ Dividend - Re 0.50/- Per Share.
Coral India Finance & Housing Limited; Annual General Meeting/Dividend - Re 1/- Per Share.
Indian Oil Corporation Limited; Annual General Meeting/ Dividend - Rs 6.60/- Per Share.
Himatsingka Seide Limited; Annual General Meeting/ Dividend - Rs 2/- Per Share.
Manappuram Finance Limited; Interim Dividend - Re 0.45/- Per Share.
Weizmann Forex Limited; Annual General Meeting/Dividend - Rs 7.50/- Per Share.
Sona Koyo Steering Systems Limited; Annual General Meeting/ Dividend - Re 0.65/- Per Share.
Orient Refractories Limited; Annual General Meeting/ Dividend - Re 1.40/- Per Share.
Weizmann Limited; Annual General Meeting/Dividend - Re 0.50/- Per Share.
Entertainment Network (India) Limited; Annual General Meeting/ Dividend - Re 1/- Per Share.
Pudumjee Pulp & Paper Mills Limited; Dividend - Re 0.30/- Per Share.
Sr.No Deal Date Security Code Security Name Client Name Deal Type Quantity Price
1 3/9/2015 534060 PMCFIN PRASUN F SINGH S 1,280,086 1.56
2 3/9/2015 534060 PMCFIN PRASUN F SINGH B 1,280,086 1.55
3 3/9/2015 538732 VGCL NAGPUR TOOLS PVT LTD B 792,000 19.50
4 3/9/2015 535136 KFL SANGAM ADVISORS LIMITED S 260,000 7.85
5 3/9/2015 535136 KFL MANJUSHA GANESH NIBHE B 260,000 7.85
6 3/9/2015 531867 UNITINT ARUNA DINESH SHAH S 240,678 5.51
7 3/9/2015 531867 UNITINT SHPL ENTERPRISES PRIVATE LIMITED S 240,396 5.50
8 3/9/2015 531867 UNITINT SHPL ENTERPRISES PRIVATE LIMITED B 239,521 5.58
9 42072 531867 UNITINT ARUNA DINESH SHAH B 238,835 5.53
10 3/9/2015 502761 BLUBLND-B ANAND ARYA B 230,001 15.20
3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Chandrakant Maske Research Associate
Ritesh Patel Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
04th Sept 2015
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kunal Parmar
Digitally signed by Kunal Parmar
DN: cn=Kunal Parmar, o=Choice Equity Broking
Pvt Ltd., ou=Research Dept.,
email=kunal.parmar@choiceindia.com, c=IN
Date: 2015.09.04 08:35:41 +05'30'